Loading stock data…
PAHC
$31.81+0.12 (+0.38%)
Market ClosedLast close Jun 29
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Phibro Animal Health Corporation in the Healthcare sector is trading at $31.81 with a market capitalization of $1.3B. Wall Street consensus targets $45.60 (5 analysts), implying a +43.4% move over the next 12 months. The stock is currently near its 52-week low of $25.32, remaining 25.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +43.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $383.54M↑ | $373.91M↑ | $363.89M↓ | $378.70M↑ | $347.82M |
| Gross Profit | $125.67M↓ | $132.66M↑ | $119.78M↑ | $110.01M↑ | $104.57M |
| Operating Income | $44.65M↓ | $50.33M↓ | $51.26M↑ | $33.72M↑ | $33.52M |
| Net Income | $24.02M↓ | $27.46M↑ | $26.53M↑ | $17.22M↓ | $20.88M |
Peer Comparison
JNJUNHPFE
Fundamentals
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mine...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.29B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.51%
ROE
Elite ROE. Management converts capital into profit efficiently.
26.32%
Volume
Today's trading volume
389,816
Recent News
Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Phibro (PAHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PAHC vs. SYK: Which Stock Is the Better Value Option?
PAHC vs. SYK: Which Stock Is the Better Value Option?
What Makes Phibro (PAHC) a New Buy Stock
Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
This animal health provider, serving global livestock markets, reported a notable insider buy in its latest SEC filing.
PAHC Stock: What's Driving Phibro's Animal Health Growth
Phibro Animal Health unit drove 74% of fiscal 2025 revenue, fueled by MFA, vaccines and global expansion, helping offset pressure in other businesses.